Difference between revisions of "CDS on FHIR"
Line 27: | Line 27: | ||
Should the name be something that allows non-true contraindications (e.g., interaction warnings)? E.g., Warning, or ContraindicationOrWarning. The severity attribute may be able to deal with this (e.g., absolute vs. relative contraindication). | Should the name be something that allows non-true contraindications (e.g., interaction warnings)? E.g., Warning, or ContraindicationOrWarning. The severity attribute may be able to deal with this (e.g., absolute vs. relative contraindication). | ||
− | What is the use case for this Resource? | + | What is the use case for this Resource? It seems like it would be for an evaluation result by a medication CDS system. |
+ | |||
+ | The severity levels do not correspond to the richer levels provided by several commercial knowledge vendors. |
Revision as of 19:48, 11 June 2015
Return to Clinical Decision Support Work Group
Project Co-Sponsors:
Project Information
This project will investigate the use of FHIR in a Clinical Decision Support context with the goal of identifying best practices for the use of FHIR in support of the primary use cases of Clinical Decision Support, namely 1) Sharing Clinical Decision Support (CDS) knowledge artifacts, and 2) Obtaining Clinical Decision Support guidance as part of a clinical workflow.
Meeting Information
The CDS on FHIR project subteam meets weekly: Conference call coordinates
Status
The Project Scope Statement for this project has been approved by the primary and co-sponsoring work groups and submitted to HL7.
Project Documents
FHIR-Based CDS Proposed Approach Slides - File:FHIR-Based CDS.pptx
Potential Issues Identified for FHIR Resources to be Officially Balloted in the Future
Contraindication
Should the name be something that allows non-true contraindications (e.g., interaction warnings)? E.g., Warning, or ContraindicationOrWarning. The severity attribute may be able to deal with this (e.g., absolute vs. relative contraindication).
What is the use case for this Resource? It seems like it would be for an evaluation result by a medication CDS system.
The severity levels do not correspond to the richer levels provided by several commercial knowledge vendors.